{"id":"aspirin-discontinuation","safety":{"commonSideEffects":[{"rate":null,"effect":"Cardiovascular events (myocardial infarction, stroke)"},{"rate":null,"effect":"Bleeding reduction"}]},"_chembl":{"chemblId":"CHEMBL25","moleculeType":"Small molecule","molecularWeight":"180.16"},"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"This is not a drug itself, but rather a clinical intervention studying what happens when aspirin is withdrawn. The trial likely examines whether discontinuation affects cardiovascular outcomes, bleeding risk, or other clinical parameters in specific patient populations. The mechanism being studied is the physiological response to removal of aspirin's antiplatelet effects.","oneSentence":"Aspirin discontinuation is a clinical trial strategy that evaluates the effects of stopping aspirin therapy in patients who have been taking it for primary or secondary prevention.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:02:43.254Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Evaluation of aspirin discontinuation in patients on chronic aspirin therapy"}]},"trialDetails":[{"nctId":"NCT07496281","phase":"PHASE4","title":"OPTIA-AF Trial: Rhythm-Guided Antithrombotic Strategy After AF Ablation","status":"NOT_YET_RECRUITING","sponsor":"Ewha Womans University Mokdong Hospital","startDate":"2027-03-01","conditions":"Atrial Fibrillation (AF), Coronary Artery Disease, Drug-eluting Stent","enrollment":2},{"nctId":"NCT06650488","phase":"PHASE4","title":"Clopidogrel vs. Aspirin for Cardiovascular Risk Reduction in Patients With S. Aureus Bacteremia","status":"RECRUITING","sponsor":"Todd C. Lee MD MPH FIDSA","startDate":"2026-01-15","conditions":"Staphylococcus Aureus Endocarditis, Staphylococcus Aureus Septicemia, Staphylococcus Aureus Bloodstream Infection","enrollment":300},{"nctId":"NCT07432516","phase":"NA","title":"Optimal Antiplatelet and Lipid Therapy in ACS With DES: OPACT Trial","status":"NOT_YET_RECRUITING","sponsor":"Yonsei University","startDate":"2026-02","conditions":"Coronary Artery Disease","enrollment":4400},{"nctId":"NCT06543082","phase":"PHASE4","title":"MACT (Mono Antiplatelet and Colchicine Therapy) Prospective Multicenter Study","status":"RECRUITING","sponsor":"CHA University","startDate":"2024-08-05","conditions":"Acute Coronary Syndrome","enrollment":490},{"nctId":"NCT05225961","phase":"PHASE4","title":"ATILA Project: Aspirin Versus Tirofiban in Endovascular Treatment for Patients With Acute Ischemic Stroke Due to Tandem Lesion","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","startDate":"2022-05-01","conditions":"Acute Ischemic Stroke","enrollment":240},{"nctId":"NCT05785897","phase":"NA","title":"STEMI Treated With a Polymer-free Sirolimus-coated Stent and P2Y12 Inhibitor-based SAPT Versus Conventional DAPT","status":"RECRUITING","sponsor":"IGLESIAS Juan Fernando","startDate":"2025-11-01","conditions":"ST Elevation Myocardial Infarction","enrollment":350},{"nctId":"NCT07358416","phase":"","title":"Complications and Antiplatelet and Anticoagulant Therapy in Vascular Surgery.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Petrovsky National Research Centre of Surgery","startDate":"2025-05-01","conditions":"Thrombosis, Bleeding, Cerebral Hypoxia During and/or Resulting From A Procedure","enrollment":500},{"nctId":"NCT03968393","phase":"PHASE4","title":"Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress","status":"RECRUITING","sponsor":"Population Health Research Institute","startDate":"2019-06-14","conditions":"Stroke, Atrial Fibrillation","enrollment":2270},{"nctId":"NCT04078568","phase":"PHASE3","title":"Efficacy of Immunoglobulin Plus Prednisolone in Reducing Coronary Artery Lesion in Patients With Kawasaki Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Hospital of Fudan University","startDate":"2020-01-15","conditions":"Kawasaki Disease","enrollment":3208},{"nctId":"NCT07198529","phase":"NA","title":"OCT-Guided Stent Optimization for Short-Duration Dual Antiplatelet Therapy in Stable Angina","status":"RECRUITING","sponsor":"Korea University Guro Hospital","startDate":"2025-09-30","conditions":"Stable Angina, Coronary Artery Disease","enrollment":130},{"nctId":"NCT05650411","phase":"NA","title":"Ultrathin-strut Biodegradable Polymer Sirolimus-eluting Stents With P2Y12 Inhibitor-based Single Antiplatelet Therapy vs. Conventional DAPT for Unprotected Left Main Coronary Artery Disease (ULTIMATE-LM)","status":"NOT_YET_RECRUITING","sponsor":"IGLESIAS Juan Fernando","startDate":"2026-03-01","conditions":"Left Main Coronary Artery Stenosis","enrollment":828},{"nctId":"NCT06742931","phase":"NA","title":"Drug-Coated Balloon Versus Drug-Eluting Stent for Treatment of De-Novo Coronary Lesions in Patients With High Bleeding Risk-2","status":"RECRUITING","sponsor":"Samsung Medical Center","startDate":"2025-04-07","conditions":"Chronic Coronary Syndrome","enrollment":1200},{"nctId":"NCT07240454","phase":"NA","title":"Aspirin Continuation or Discontinuation in Conservative Treatment for Chronic Subdural Hematoma","status":"RECRUITING","sponsor":"Tao Liu","startDate":"2025-10-15","conditions":"Chronic Subdural Hematoma","enrollment":143},{"nctId":"NCT04755387","phase":"PHASE4","title":"Ticagrelor De-escalation Strategy in AMI Patients","status":"RECRUITING","sponsor":"Dong-A University","startDate":"2023-03-27","conditions":"Acute Myocardial Infarction","enrollment":2312},{"nctId":"NCT04360720","phase":"PHASE3","title":"Percutaneous Coronary Intervention Followed by Antiplatelet Monotherapy in the Setting of Acute Coronary Syndromes","status":"COMPLETED","sponsor":"Hospital Israelita Albert Einstein","startDate":"2020-10-15","conditions":"Acute Coronary Syndrome","enrollment":3410},{"nctId":"NCT06108947","phase":"NA","title":"Screening for Preeclampsia in Norway With Aspirin Discontinuation at 24-28 Weeks","status":"RECRUITING","sponsor":"St. Olavs Hospital","startDate":"2024-01-01","conditions":"Pre-Eclampsia","enrollment":300},{"nctId":"NCT06952712","phase":"PHASE3","title":"Aspirin 150 mg vs 100 mg for Prevention of Preeclampsia in High-Risk Obese Pregnant Women","status":"NOT_YET_RECRUITING","sponsor":"FANG HE","startDate":"2025-05-07","conditions":"Preeclampsia","enrollment":1300},{"nctId":"NCT05767723","phase":"PHASE4","title":"Platelet Sub-study of the Neomindset Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hospital Israelita Albert Einstein","startDate":"2023-02-06","conditions":"Acute Coronary Syndrome","enrollment":48},{"nctId":"NCT04484259","phase":"PHASE4","title":"Ticagrelor With and Without Aspirin in Patients With Diabetes Mellitus","status":"COMPLETED","sponsor":"University of Florida","startDate":"2021-03-31","conditions":"Diabetes Mellitus, Type 2, Coronary Artery Disease","enrollment":105},{"nctId":"NCT06518317","phase":"PHASE3","title":"Short Versus Long Antiplatelet Therapy After TAVI","status":"RECRUITING","sponsor":"University Hospital, Caen","startDate":"2024-11-21","conditions":"Transcatheter Aortic Valve Replacement","enrollment":1400},{"nctId":"NCT06693362","phase":"PHASE1","title":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Safety and Efficacy of Uterine Blood Mesenchymal Stem Cells Injection for the Treatment of Severe Pneumonia Caused by Viruses","status":"RECRUITING","sponsor":"Ruijin Hospital","startDate":"2025-01-20","conditions":"Severe Viral Pneumonia(Not Include COVID-19)","enrollment":60},{"nctId":"NCT06742567","phase":"PHASE3","title":"Apixaban Prophylaxis for Prevention of Left Ventricular Thrombus Following Anterior Myocardial Infarction","status":"RECRUITING","sponsor":"National Institute of Cardiovascular Diseases, Pakistan","startDate":"2024-12-02","conditions":"Acute Myocardial Infarction of Anterior Wall, Left Ventricular Thrombus, Prophylaxis","enrollment":472},{"nctId":"NCT06739395","phase":"PHASE2","title":"Precision Medicine Trial Based on Molecular Matching Therapy for Patients With Standard Treatment Exhaustion","status":"RECRUITING","sponsor":"Tianjin Medical University Second Hospital","startDate":"2024-11-01","conditions":"Solid Tumor, Precision Medicine","enrollment":300},{"nctId":"NCT03152058","phase":"PHASE2","title":"IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy","status":"RECRUITING","sponsor":"David Ware Branch","startDate":"2017-05-17","conditions":"High Risk Pregnancy, Pregnancy Complications, Antiphospholipid Syndrome in Pregnancy","enrollment":55},{"nctId":"NCT05955365","phase":"PHASE4","title":"Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation","status":"RECRUITING","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2023-12-18","conditions":"Percutaneous Coronary Intervention (PCI), Atrial Fibrillation (AF), Oral Anticoagulation","enrollment":3010},{"nctId":"NCT02513914","phase":"NA","title":"Operative Procedures Vs. Endovascular Neurosurgery for Untreated Pseudotumor Trial","status":"SUSPENDED","sponsor":"St. Joseph's Hospital and Medical Center, Phoenix","startDate":"2020-06-03","conditions":"Pseudotumor Cerebri, Idiopathic Intracranial Hypertension (IIH)","enrollment":80},{"nctId":"NCT05117866","phase":"NA","title":"Acetyl Salicylic Elimination Trial JAPAN: The ASET JAPAN Pilot Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Meditrix Corp","startDate":"2020-09-15","conditions":"Chronic Coronary Syndrome, Non ST Segment Elevation Acute Coronary Syndrome","enrollment":307},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000},{"nctId":"NCT06111079","phase":"PHASE3","title":"Aspirin Discontinuation in High-Risk Pregnant Women of Preeclampsia","status":"RECRUITING","sponsor":"FANG HE","startDate":"2023-11-01","conditions":"Preeclampsia, Perinatal Haemorrhage","enrollment":1800},{"nctId":"NCT06478537","phase":"PHASE2","title":"TPO-RA Treatment on Immune Tolerance Induction of ITP Patients With Sustained Platelet Recovery After Treatment Termination","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2024-06-20","conditions":"Immune Thrombocytopenia","enrollment":56},{"nctId":"NCT04971356","phase":"NA","title":"1-month DAPT Plus 5-month Ticagrelor Monotherapy Versus 12-month DAPT in Patients With Drug-coated Balloon","status":"ACTIVE_NOT_RECRUITING","sponsor":"Xijing Hospital","startDate":"2021-11-01","conditions":"Antiplatelet Drug, Acute Coronary Syndrome, Angioplasty, Balloon","enrollment":1948},{"nctId":"NCT06018688","phase":"PHASE2","title":"Osimertinib Combined With Aspirin Neoadjuvant Therapy for Resectable EGFR Mutated NSCLC Patients.","status":"NOT_YET_RECRUITING","sponsor":"Daping Hospital and the Research Institute of Surgery of the Third Military Medical University","startDate":"2023-09-15","conditions":"Non Small Cell Lung Cancer, EGFR Gene Mutation","enrollment":44},{"nctId":"NCT04718025","phase":"PHASE3","title":"Evaluation of Safety and Efficacy of Two Ticagrelor-based De-escalation Antiplatelet Strategies in Acute Coronary Syndrome","status":"UNKNOWN","sponsor":"Collegium Medicum w Bydgoszczy","startDate":"2022-02-07","conditions":"STEMI, NSTEMI, Unstable Angina","enrollment":4500},{"nctId":"NCT05705089","phase":"PHASE3","title":"Rivaroxaban vErsus Warfarin for Antithrombotic TheRapy in Patients With LeFt Ventricular Thrombus After Acute STEMI","status":"COMPLETED","sponsor":"Rajaie Cardiovascular Medical and Research Center","startDate":"2020-07-30","conditions":"Left Ventricular Thrombus, ST Segment Elevation Myocardial Infarction","enrollment":50},{"nctId":"NCT02659384","phase":"PHASE2","title":"Anti-programmed Cell Death-1 Ligand 1 (aPDL-1) Antibody Atezolizumab, Bevacizumab and Acetylsalicylic Acid in Recurrent Platinum Resistant Ovarian Cancer","status":"COMPLETED","sponsor":"European Organisation for Research and Treatment of Cancer - EORTC","startDate":"2016-12-23","conditions":"Ovarian Neoplasms","enrollment":122},{"nctId":"NCT02420652","phase":"PHASE2","title":"Metformin Hydrochloride and Aspirin in Treating Patients With Hormone-Dependent Prostate Cancer That Has Progressed After Surgery or Radiation Therapy","status":"TERMINATED","sponsor":"Rutgers, The State University of New Jersey","startDate":"2015-06-23","conditions":"Recurrent Prostate Carcinoma, Stage I Prostate Cancer, Stage IIA Prostate Cancer","enrollment":27},{"nctId":"NCT04949516","phase":"PHASE4","title":"Mono Antiplatelet and Colchicine Therapy","status":"COMPLETED","sponsor":"Wonkwang University Hospital","startDate":"2021-06-15","conditions":"Acute Coronary Syndrome, Drug-Eluting Stents","enrollment":200},{"nctId":"NCT05035277","phase":"PHASE3","title":"AntiCoagulation Versus AcetylSalicylic Acid After Transcatheter Aortic Valve Implantation","status":"RECRUITING","sponsor":"Oslo University Hospital","startDate":"2021-12-04","conditions":"Aortic Stenosis","enrollment":360},{"nctId":"NCT05599152","phase":"","title":"Comparison of Myocardial Infarction Patients Who Were Prescribed a Novel Antiplatelet Agent or Clopidogrel","status":"UNKNOWN","sponsor":"Chan Joon Kim","startDate":"2020-05-21","conditions":"Myocardial Infarction","enrollment":3000},{"nctId":"NCT03815175","phase":"NA","title":"XIENCE 28 USA Study","status":"COMPLETED","sponsor":"Abbott Medical Devices","startDate":"2019-02-25","conditions":"Bleeding Disorder, Ischemic Stroke, Hemorrhagic Stroke","enrollment":1605},{"nctId":"NCT05151796","phase":"","title":"Continuation of Aspirin Before Isolated Heart Valve Surgery","status":"UNKNOWN","sponsor":"University of Liege","startDate":"2012-05-01","conditions":"Isolated Heart Valve Surgery","enrollment":500},{"nctId":"NCT01641107","phase":"PHASE2","title":"Phase II Front-line Ponatinib in Adult Philadelphia+/BCR-ABL+ Acute Lymphoblastic Leukemia.","status":"COMPLETED","sponsor":"Incyte Corporation","startDate":"2014-12-04","conditions":"Philadelphia Positive, BCR-ABL Positive, Acute Lymphoblastic Leukemia","enrollment":44},{"nctId":"NCT03218787","phase":"NA","title":"XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.","status":"COMPLETED","sponsor":"Abbott Medical Devices","startDate":"2017-07-19","conditions":"Coronary Artery Lesions","enrollment":2047},{"nctId":"NCT04695106","phase":"PHASE4","title":"Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI","status":"RECRUITING","sponsor":"Medical University of Gdansk","startDate":"2021-10-25","conditions":"Atrial Fibrillation, Antithrombotic Therapy, Acute Coronary Syndrome","enrollment":2230},{"nctId":"NCT03821883","phase":"NA","title":"Aspirin Discontinuation After Left Atrial Appendage Occlusion in Atrial Fibrillation","status":"UNKNOWN","sponsor":"Xinhua Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2020-06-01","conditions":"Atrial Fibrillation, Stroke, Bleeding","enrollment":1120},{"nctId":"NCT03023020","phase":"NA","title":"Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Prolonged DAPT Regimen","status":"COMPLETED","sponsor":"ECRI bv","startDate":"2017-04-04","conditions":"High Bleeding Risk, Coronary Artery Disease, PCI","enrollment":4579},{"nctId":"NCT04995159","phase":"NA","title":"Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVas™ BRS System","status":"NOT_YET_RECRUITING","sponsor":"Lepu Medical Technology (Beijing) Co., Ltd.","startDate":"2021-09","conditions":"Coronary Heart Disease","enrollment":2150},{"nctId":"NCT04943146","phase":"","title":"An Assessment of Aspirin Plus Prednisone Treatment for Euthyroid Women With Thyroid Autoimmunity","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2021-03-01","conditions":"Thyroid Diseases","enrollment":402},{"nctId":"NCT01014624","phase":"PHASE4","title":"Prasugrel/Clopidogrel Maintenance Dose Washout Study","status":"COMPLETED","sponsor":"Daiichi Sankyo","startDate":"2010-02","conditions":"Coronary Artery Disease","enrollment":56},{"nctId":"NCT03579732","phase":"","title":"EffectiveNess of Low Dose Aspirin in GastrointEstinal Cancer Prevention - Taiwan","status":"COMPLETED","sponsor":"Bayer","startDate":"2018-06-29","conditions":"Colorectal Neoplasms","enrollment":4710504},{"nctId":"NCT04501900","phase":"PHASE4","title":"The 3 Years vs 1 Year DAPT After XINSORB BRS Implantation","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2020-10","conditions":"Cardiovascular Diseases","enrollment":2106},{"nctId":"NCT02556203","phase":"PHASE3","title":"Global Study Comparing a rivAroxaban-based Antithrombotic Strategy to an antipLatelet-based Strategy After Transcatheter aortIc vaLve rEplacement to Optimize Clinical Outcomes","status":"TERMINATED","sponsor":"Bayer","startDate":"2015-12-16","conditions":"Transcatheter Aortic Valve Replacement","enrollment":1653},{"nctId":"NCT02350543","phase":"PHASE4","title":"Peri-operative Aspirin Continuation Versus Discontinuation","status":"TERMINATED","sponsor":"Rabin Medical Center","startDate":"2015-02","conditions":"Hematuria, Urinary Bladder Neoplasms","enrollment":50},{"nctId":"NCT01221181","phase":"PHASE1","title":"Eculizumab Therapy for Dense Deposit Disease and C3 Nephropathy","status":"COMPLETED","sponsor":"Columbia University","startDate":"2010-07","conditions":"Dense Deposit Disease, Membranoproliferative Glomerulonephritis","enrollment":6},{"nctId":"NCT02696226","phase":"NA","title":"Frequency of Reduced Leaflet Motion After Surgical Aortic Valve Replacement and Transcatheter Aortic Valve Replacement.","status":"TERMINATED","sponsor":"The Cleveland Clinic","startDate":"2016-02","conditions":"Aortic Valve Disorder","enrollment":3},{"nctId":"NCT01962545","phase":"PHASE4","title":"Optimizing Antithrombotic Care in Patients With AtriaL fibrillatiON and Coronary stEnt (OAC-ALONE) Study","status":"COMPLETED","sponsor":"Satoshi Shizuta","startDate":"2013-11-05","conditions":"Atrial Fibrillation, Coronary Artery Disease","enrollment":690},{"nctId":"NCT00619073","phase":"NA","title":"PACT (Platelet Activity After Clopidogrel Termination)","status":"COMPLETED","sponsor":"University of Massachusetts, Worcester","startDate":"2008-04","conditions":"Blood Platelets, Clopidogrel","enrollment":15},{"nctId":"NCT03184805","phase":"NA","title":"STOPping Versus Continuing Antiplatelet Therapy During Noncardiac Surgery and Procedures After Next Generation Drug-eluting Stent Implantation","status":"TERMINATED","sponsor":"Yonsei University","startDate":"2017-06-23","conditions":"Coronary Artery Disease","enrollment":140},{"nctId":"NCT03469856","phase":"NA","title":"Acetyl Salicylic Elimination Trial: The ASET Pilot Study","status":"UNKNOWN","sponsor":"Pedro A. Lemos","startDate":"2018-02-22","conditions":"Monotherapy After PCI","enrollment":200},{"nctId":"NCT01433978","phase":"PHASE3","title":"A Phase 3, Multicenter, Randomized, Double-blind,Active-controlled, Parallel-group Trial With an Open-labelExtension Phase to Evaluate the Efficacy and Safety of OralE5501 Versus Eltrombopag, in Adults With Chronic ImmuneThrombocytopenia (Idiopathic Thrombocytopenic Purpura)","status":"TERMINATED","sponsor":"Eisai Inc.","startDate":"2012-03-26","conditions":"Idiopathic Thrombocytopenic Purpura","enrollment":24},{"nctId":"NCT01438840","phase":"PHASE3","title":"Efficacy and Safety of Oral E5501 Plus Standard of Care for the Treatment of Thrombocytopenia in Adults With Chronic Immune Thrombocytopenia (Amendment 02)","status":"COMPLETED","sponsor":"Eisai Inc.","startDate":"2012-02-16","conditions":"Chronic Thrombocytopenia, Immune Thrombocytopenia","enrollment":49},{"nctId":"NCT02492230","phase":"PHASE2","title":"Left Atrial Appendage Closure Compared to Standard Antiplatelet Therapy in Patients With AF Who Underwent PCI","status":"UNKNOWN","sponsor":"Meshalkin Research Institute of Pathology of Circulation","startDate":"2015-05","conditions":"Myocardial Infarction","enrollment":50},{"nctId":"NCT01459627","phase":"PHASE4","title":"Randomized, Open Label Trial of 6 Months Versus 12 Months DAPT After Drug-Eluting Stent in STEMI","status":"COMPLETED","sponsor":"Maasstad Hospital","startDate":"2011-12","conditions":"Myocardial Infarction, Cardiovascular Disease","enrollment":1100},{"nctId":"NCT03088072","phase":"PHASE4","title":"A Pilot Study of Edoxaban in Patients With Non-Valvular Atrial Fibrillation and Left Atrial Appendage Closure","status":"UNKNOWN","sponsor":"Scripps Health","startDate":"2017-03-23","conditions":"Non-Valvular Atrial Fibrillation, Left Atrial Appendage Closure","enrollment":75},{"nctId":"NCT03049566","phase":"","title":"Low-dose Acetylsalicylic Acid Before Non-cardiac Surgery","status":"COMPLETED","sponsor":"Universitätsklinikum Hamburg-Eppendorf","startDate":"2014-02-10","conditions":"Surgery, Platelet Dysfunction","enrollment":805},{"nctId":"NCT02865824","phase":"NA","title":"Polypectomy in Patients Taking Dual Antiplatelet Agents","status":"UNKNOWN","sponsor":"Incheon St.Mary's Hospital","startDate":"2016-01","conditions":"Colonic Polyps","enrollment":180},{"nctId":"NCT02837003","phase":"","title":"3-Month Discontinuation of Dual Antiplatelet Therapy After Ultimaster Sirolimus-Eluting Stent Implantation","status":"UNKNOWN","sponsor":"Teikyo University","startDate":"2016-07","conditions":"Coronary Artery Disease","enrollment":1500},{"nctId":"NCT00833833","phase":"PHASE1, PHASE2","title":"MTD, Safety, and Efficacy of Pomalidomide (CC-4047) Alone or With Low-dose Dexamethasone in Patients With Relapsed and Refractory Multiple Myeloma","status":"COMPLETED","sponsor":"Celgene Corporation","startDate":"2008-06","conditions":"Multiple Myeloma","enrollment":259},{"nctId":"NCT02209909","phase":"NA","title":"Effects of Low Dose Aspirin Pre-treatment on Platelet Activation Undergoing Off-pump Coronary Artery Bypass Surgery","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2014-07","conditions":"Coronary Artery Disease","enrollment":48},{"nctId":"NCT02744937","phase":"PHASE4","title":"Continuing Low Dose Aspirin Before Prostate Biopsy","status":"UNKNOWN","sponsor":"National Taiwan University Hospital","startDate":"2016-04","conditions":"Complication","enrollment":150},{"nctId":"NCT01869309","phase":"PHASE4","title":"Overcoming High On-Treatment Platelet Reactivity (HPR) During Prasugrel Therapy With Ticagrelor","status":"UNKNOWN","sponsor":"LifeBridge Health","startDate":"2014-01","conditions":"Coronary Artery Disease","enrollment":400},{"nctId":"NCT02293928","phase":"","title":"Impact of Hybrid Coronary Revascularization on Antiplatelet Therapy","status":"COMPLETED","sponsor":"Aarhus University Hospital Skejby","startDate":"2010-10","conditions":"Coronary Artery Disease","enrollment":40},{"nctId":"NCT00358735","phase":"NA","title":"Deep Vein Thrombosis (DVT) Prevention in Total Hip Arthroplasty: Continuous Enhanced Circulation Therapy (CECT) Versus Low Molecular Weight Heparin (LMWH)","status":"COMPLETED","sponsor":"Medical Compression Systems","startDate":"2006-06","conditions":"Deep Vein Thrombosis of Lower Limb, Pulmonary Embolism (PE), Bleeding","enrollment":411},{"nctId":"NCT01888575","phase":"","title":"Assessment of Low-dose ASA Discontinuation Risk Associated With Concomitant PPI Use During the First Year of ASA Therapy","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2012-09","conditions":"Cardiovascular Prevention","enrollment":35604},{"nctId":"NCT00479362","phase":"PHASE4","title":"Anticoagulant Therapy During Pacemaker Implantation","status":"COMPLETED","sponsor":"University of Turku","startDate":"2005-09","conditions":"Hemorrhage, Thrombosis, Embolism","enrollment":447},{"nctId":"NCT00484926","phase":"PHASE4","title":"Association of Clopidogrel Therapy and Stent Thrombosis","status":"COMPLETED","sponsor":"Seung-Jung Park","startDate":"2007-03","conditions":"Coronary Artery Disease","enrollment":2000},{"nctId":"NCT01470040","phase":"PHASE4","title":"Does Discontinuation of Aspirin Treatment Following Head Trauma Decrease the Incidence of Chronic Subdural Hematoma?","status":"UNKNOWN","sponsor":"Hadassah Medical Organization","startDate":"2012-02","conditions":"Head Trauma, Traumatic Brain Injury, Chronic Subdural Hematoma","enrollment":100},{"nctId":"NCT01476020","phase":"","title":"Is There A LIfe for Drug Eluting Stent (DES) After Discontinuation of Clopidogrel","status":"UNKNOWN","sponsor":"Gilard, Martine","startDate":"2011-11","conditions":"Restenosis","enrollment":1240},{"nctId":"NCT00493779","phase":"PHASE4","title":"A Study to Evaluate the Discontinuation Effect of Clopidogrel After Drug Eluting Stent Implantation in Non-diabetic Patients","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2007-10","conditions":"Antiplatelet Aggregation","enrollment":103},{"nctId":"NCT00564174","phase":"NA","title":"Low Molecular Weight Heparin and Aspirin in the Treatment of Recurrent Pregnancy Loss: A RCT","status":"TERMINATED","sponsor":"Mount Sinai Hospital, Canada","startDate":"2000-03","conditions":"Recurrent Pregnancy Loss, Antiphospholipid Antibody Syndrome","enrollment":88}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":97,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["initiation of aspirin in early pregnancy"],"phase":"phase_3","status":"active","brandName":"aspirin discontinuation","genericName":"aspirin discontinuation","companyName":"Seoul National University Hospital","companyId":"seoul-national-university-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Aspirin discontinuation is a clinical trial strategy that evaluates the effects of stopping aspirin therapy in patients who have been taking it for primary or secondary prevention. Used for Evaluation of aspirin discontinuation in patients on chronic aspirin therapy.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}